nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—HTR2A—pancreatitis	0.173	1	CbGaD
Ziprasidone—CHRM4—Hyoscyamine—pancreatitis	0.137	0.22	CbGbCtD
Ziprasidone—CHRM3—Propantheline—pancreatitis	0.0961	0.154	CbGbCtD
Ziprasidone—CHRM3—Hyoscyamine—pancreatitis	0.0857	0.138	CbGbCtD
Ziprasidone—CHRM1—Propantheline—pancreatitis	0.0836	0.134	CbGbCtD
Ziprasidone—CHRM2—Propantheline—pancreatitis	0.0771	0.124	CbGbCtD
Ziprasidone—CHRM1—Hyoscyamine—pancreatitis	0.0745	0.12	CbGbCtD
Ziprasidone—CHRM2—Hyoscyamine—pancreatitis	0.0687	0.11	CbGbCtD
Ziprasidone—Heat stroke—Propantheline—pancreatitis	0.0107	0.105	CcSEcCtD
Ziprasidone—Pulse irregular—Hyoscyamine—pancreatitis	0.00868	0.0848	CcSEcCtD
Ziprasidone—Heart rate irregular—Hyoscyamine—pancreatitis	0.00372	0.0363	CcSEcCtD
Ziprasidone—Enuresis—Hyoscyamine—pancreatitis	0.0035	0.0342	CcSEcCtD
Ziprasidone—Hyperpyrexia—Hyoscyamine—pancreatitis	0.00269	0.0262	CcSEcCtD
Ziprasidone—Rash papular—Hyoscyamine—pancreatitis	0.00269	0.0262	CcSEcCtD
Ziprasidone—Dermatitis atopic—Propantheline—pancreatitis	0.00264	0.0258	CcSEcCtD
Ziprasidone—Hyperreflexia—Hyoscyamine—pancreatitis	0.00217	0.0212	CcSEcCtD
Ziprasidone—Salivary hypersecretion—Propantheline—pancreatitis	0.0019	0.0185	CcSEcCtD
Ziprasidone—Blepharitis—Hyoscyamine—pancreatitis	0.00163	0.0159	CcSEcCtD
Ziprasidone—Electrocardiogram QT prolonged—Hyoscyamine—pancreatitis	0.00156	0.0152	CcSEcCtD
Ziprasidone—Keratitis—Hyoscyamine—pancreatitis	0.00154	0.0151	CcSEcCtD
Ziprasidone—Thirst—Propantheline—pancreatitis	0.00149	0.0146	CcSEcCtD
Ziprasidone—Paralysis—Hyoscyamine—pancreatitis	0.00144	0.0141	CcSEcCtD
Ziprasidone—Mania—Hyoscyamine—pancreatitis	0.00138	0.0134	CcSEcCtD
Ziprasidone—Lurasidone—HTR2A—pancreatitis	0.00137	0.623	CrCbGaD
Ziprasidone—Laryngospasm—Hyoscyamine—pancreatitis	0.00134	0.0131	CcSEcCtD
Ziprasidone—Feeling hot—Hyoscyamine—pancreatitis	0.00128	0.0125	CcSEcCtD
Ziprasidone—Dysphagia—Propantheline—pancreatitis	0.00123	0.012	CcSEcCtD
Ziprasidone—Delirium—Hyoscyamine—pancreatitis	0.00116	0.0114	CcSEcCtD
Ziprasidone—Speech disorder—Hyoscyamine—pancreatitis	0.00116	0.0114	CcSEcCtD
Ziprasidone—Erectile dysfunction—Propantheline—pancreatitis	0.00113	0.011	CcSEcCtD
Ziprasidone—Gastrooesophageal reflux disease—Hyoscyamine—pancreatitis	0.00111	0.0108	CcSEcCtD
Ziprasidone—Leukocytosis—Hyoscyamine—pancreatitis	0.00107	0.0104	CcSEcCtD
Ziprasidone—Dysarthria—Hyoscyamine—pancreatitis	0.00106	0.0103	CcSEcCtD
Ziprasidone—Muscle twitching—Hyoscyamine—pancreatitis	0.00102	0.00995	CcSEcCtD
Ziprasidone—Dermatitis contact—Hyoscyamine—pancreatitis	0.000989	0.00966	CcSEcCtD
Ziprasidone—Blood urea increased—Hyoscyamine—pancreatitis	0.000945	0.00923	CcSEcCtD
Ziprasidone—Photophobia—Hyoscyamine—pancreatitis	0.00094	0.00918	CcSEcCtD
Ziprasidone—Dry eye—Hyoscyamine—pancreatitis	0.000924	0.00903	CcSEcCtD
Ziprasidone—Rash maculo-papular—Hyoscyamine—pancreatitis	0.00091	0.00888	CcSEcCtD
Ziprasidone—Hypertonia—Hyoscyamine—pancreatitis	0.000877	0.00857	CcSEcCtD
Ziprasidone—Hyperkinesia—Hyoscyamine—pancreatitis	0.000873	0.00852	CcSEcCtD
Ziprasidone—Eczema—Hyoscyamine—pancreatitis	0.000808	0.00789	CcSEcCtD
Ziprasidone—Vision blurred—Propantheline—pancreatitis	0.000806	0.00786	CcSEcCtD
Ziprasidone—Amnesia—Hyoscyamine—pancreatitis	0.000773	0.00755	CcSEcCtD
Ziprasidone—Atrial fibrillation—Hyoscyamine—pancreatitis	0.000767	0.00749	CcSEcCtD
Ziprasidone—Thirst—Hyoscyamine—pancreatitis	0.000763	0.00745	CcSEcCtD
Ziprasidone—Palpitations—Propantheline—pancreatitis	0.000755	0.00737	CcSEcCtD
Ziprasidone—Hypoglycaemia—Hyoscyamine—pancreatitis	0.000744	0.00727	CcSEcCtD
Ziprasidone—Lethargy—Hyoscyamine—pancreatitis	0.000741	0.00724	CcSEcCtD
Ziprasidone—Hyponatraemia—Hyoscyamine—pancreatitis	0.000729	0.00712	CcSEcCtD
Ziprasidone—Osteoarthritis—Hyoscyamine—pancreatitis	0.000727	0.00709	CcSEcCtD
Ziprasidone—Dry mouth—Propantheline—pancreatitis	0.000712	0.00695	CcSEcCtD
Ziprasidone—Psychotic disorder—Hyoscyamine—pancreatitis	0.00071	0.00693	CcSEcCtD
Ziprasidone—Confusional state—Propantheline—pancreatitis	0.000703	0.00687	CcSEcCtD
Ziprasidone—Urinary retention—Hyoscyamine—pancreatitis	0.000691	0.00675	CcSEcCtD
Ziprasidone—Ataxia—Hyoscyamine—pancreatitis	0.000683	0.00667	CcSEcCtD
Ziprasidone—Tachycardia—Propantheline—pancreatitis	0.000681	0.00665	CcSEcCtD
Ziprasidone—Dehydration—Hyoscyamine—pancreatitis	0.000676	0.0066	CcSEcCtD
Ziprasidone—Hypokalaemia—Hyoscyamine—pancreatitis	0.000661	0.00646	CcSEcCtD
Ziprasidone—Insomnia—Propantheline—pancreatitis	0.000631	0.00616	CcSEcCtD
Ziprasidone—Dysphagia—Hyoscyamine—pancreatitis	0.000628	0.00613	CcSEcCtD
Ziprasidone—Somnolence—Propantheline—pancreatitis	0.00062	0.00605	CcSEcCtD
Ziprasidone—Angina pectoris—Hyoscyamine—pancreatitis	0.000612	0.00597	CcSEcCtD
Ziprasidone—Constipation—Propantheline—pancreatitis	0.000597	0.00582	CcSEcCtD
Ziprasidone—Dysuria—Hyoscyamine—pancreatitis	0.000587	0.00573	CcSEcCtD
Ziprasidone—Erectile dysfunction—Hyoscyamine—pancreatitis	0.000578	0.00565	CcSEcCtD
Ziprasidone—Feeling abnormal—Propantheline—pancreatitis	0.000575	0.00561	CcSEcCtD
Ziprasidone—Hyperglycaemia—Hyoscyamine—pancreatitis	0.000566	0.00553	CcSEcCtD
Ziprasidone—Urticaria—Propantheline—pancreatitis	0.000554	0.00541	CcSEcCtD
Ziprasidone—Conjunctivitis—Hyoscyamine—pancreatitis	0.000544	0.00531	CcSEcCtD
Ziprasidone—Sweating—Hyoscyamine—pancreatitis	0.000537	0.00524	CcSEcCtD
Ziprasidone—Hypersensitivity—Propantheline—pancreatitis	0.000514	0.00502	CcSEcCtD
Ziprasidone—Bradycardia—Hyoscyamine—pancreatitis	0.000512	0.005	CcSEcCtD
Ziprasidone—Asthenia—Propantheline—pancreatitis	0.0005	0.00489	CcSEcCtD
Ziprasidone—Dizziness—Propantheline—pancreatitis	0.000461	0.0045	CcSEcCtD
Ziprasidone—Arrhythmia—Hyoscyamine—pancreatitis	0.000449	0.00438	CcSEcCtD
Ziprasidone—Vomiting—Propantheline—pancreatitis	0.000444	0.00433	CcSEcCtD
Ziprasidone—Mental disorder—Hyoscyamine—pancreatitis	0.00044	0.0043	CcSEcCtD
Ziprasidone—Rash—Propantheline—pancreatitis	0.00044	0.00429	CcSEcCtD
Ziprasidone—Dermatitis—Propantheline—pancreatitis	0.000439	0.00429	CcSEcCtD
Ziprasidone—Erythema—Hyoscyamine—pancreatitis	0.000438	0.00427	CcSEcCtD
Ziprasidone—Headache—Propantheline—pancreatitis	0.000437	0.00427	CcSEcCtD
Ziprasidone—Nausea—Propantheline—pancreatitis	0.000414	0.00405	CcSEcCtD
Ziprasidone—Vision blurred—Hyoscyamine—pancreatitis	0.000412	0.00403	CcSEcCtD
Ziprasidone—Agitation—Hyoscyamine—pancreatitis	0.000402	0.00393	CcSEcCtD
Ziprasidone—Angioedema—Hyoscyamine—pancreatitis	0.0004	0.0039	CcSEcCtD
Ziprasidone—Vertigo—Hyoscyamine—pancreatitis	0.000393	0.00384	CcSEcCtD
Ziprasidone—Syncope—Hyoscyamine—pancreatitis	0.000392	0.00383	CcSEcCtD
Ziprasidone—Palpitations—Hyoscyamine—pancreatitis	0.000387	0.00378	CcSEcCtD
Ziprasidone—Loss of consciousness—Hyoscyamine—pancreatitis	0.000385	0.00375	CcSEcCtD
Ziprasidone—Chest pain—Hyoscyamine—pancreatitis	0.000373	0.00364	CcSEcCtD
Ziprasidone—Anxiety—Hyoscyamine—pancreatitis	0.000371	0.00362	CcSEcCtD
Ziprasidone—Dry mouth—Hyoscyamine—pancreatitis	0.000364	0.00356	CcSEcCtD
Ziprasidone—Confusional state—Hyoscyamine—pancreatitis	0.00036	0.00352	CcSEcCtD
Ziprasidone—Shock—Hyoscyamine—pancreatitis	0.000351	0.00343	CcSEcCtD
Ziprasidone—Tachycardia—Hyoscyamine—pancreatitis	0.000349	0.0034	CcSEcCtD
Ziprasidone—Hyperhidrosis—Hyoscyamine—pancreatitis	0.000345	0.00337	CcSEcCtD
Ziprasidone—Hypotension—Hyoscyamine—pancreatitis	0.000334	0.00326	CcSEcCtD
Ziprasidone—Aripiprazole—HTR2A—pancreatitis	0.000328	0.149	CrCbGaD
Ziprasidone—Trazodone—HTR2A—pancreatitis	0.000326	0.148	CrCbGaD
Ziprasidone—Insomnia—Hyoscyamine—pancreatitis	0.000323	0.00315	CcSEcCtD
Ziprasidone—Dyspnoea—Hyoscyamine—pancreatitis	0.000318	0.00311	CcSEcCtD
Ziprasidone—Somnolence—Hyoscyamine—pancreatitis	0.000317	0.0031	CcSEcCtD
Ziprasidone—Dyspepsia—Hyoscyamine—pancreatitis	0.000314	0.00307	CcSEcCtD
Ziprasidone—Fatigue—Hyoscyamine—pancreatitis	0.000308	0.00301	CcSEcCtD
Ziprasidone—Constipation—Hyoscyamine—pancreatitis	0.000305	0.00298	CcSEcCtD
Ziprasidone—Feeling abnormal—Hyoscyamine—pancreatitis	0.000294	0.00287	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.000292	0.00285	CcSEcCtD
Ziprasidone—Urticaria—Hyoscyamine—pancreatitis	0.000284	0.00277	CcSEcCtD
Ziprasidone—Body temperature increased—Hyoscyamine—pancreatitis	0.000282	0.00276	CcSEcCtD
Ziprasidone—Abdominal pain—Hyoscyamine—pancreatitis	0.000282	0.00276	CcSEcCtD
Ziprasidone—Hypersensitivity—Hyoscyamine—pancreatitis	0.000263	0.00257	CcSEcCtD
Ziprasidone—Asthenia—Hyoscyamine—pancreatitis	0.000256	0.0025	CcSEcCtD
Ziprasidone—Diarrhoea—Hyoscyamine—pancreatitis	0.000244	0.00239	CcSEcCtD
Ziprasidone—Dizziness—Hyoscyamine—pancreatitis	0.000236	0.00231	CcSEcCtD
Ziprasidone—Vomiting—Hyoscyamine—pancreatitis	0.000227	0.00222	CcSEcCtD
Ziprasidone—Rash—Hyoscyamine—pancreatitis	0.000225	0.0022	CcSEcCtD
Ziprasidone—Dermatitis—Hyoscyamine—pancreatitis	0.000225	0.0022	CcSEcCtD
Ziprasidone—Headache—Hyoscyamine—pancreatitis	0.000224	0.00218	CcSEcCtD
Ziprasidone—Nausea—Hyoscyamine—pancreatitis	0.000212	0.00207	CcSEcCtD
Ziprasidone—Clozapine—HTR2A—pancreatitis	0.000176	0.0799	CrCbGaD
Ziprasidone—DRD2—Signaling by GPCR—NRAS—pancreatitis	3.35e-06	3.38e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—GCG—pancreatitis	3.33e-06	3.37e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—LEP—pancreatitis	3.32e-06	3.36e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—NRAS—pancreatitis	3.3e-06	3.33e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—NRAS—pancreatitis	3.29e-06	3.32e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—KRAS—pancreatitis	3.28e-06	3.32e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—CASP3—pancreatitis	3.28e-06	3.32e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—NRAS—pancreatitis	3.28e-06	3.31e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—NRAS—pancreatitis	3.27e-06	3.3e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—CXCL8—pancreatitis	3.27e-06	3.3e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—KRAS—pancreatitis	3.27e-06	3.3e-05	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—HRAS—pancreatitis	3.26e-06	3.29e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling by GPCR—IL6—pancreatitis	3.26e-06	3.29e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—HRAS—pancreatitis	3.24e-06	3.28e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—NRAS—pancreatitis	3.24e-06	3.27e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—NRAS—pancreatitis	3.23e-06	3.26e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—CXCL8—pancreatitis	3.22e-06	3.26e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—HRAS—pancreatitis	3.2e-06	3.24e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—KRAS—pancreatitis	3.18e-06	3.21e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PPARG—pancreatitis	3.17e-06	3.2e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—INS—pancreatitis	3.17e-06	3.2e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—KRAS—pancreatitis	3.13e-06	3.16e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—CASP3—pancreatitis	3.13e-06	3.16e-05	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—IL6—pancreatitis	3.12e-06	3.15e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—INS—pancreatitis	3.12e-06	3.15e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CCL2—pancreatitis	3.12e-06	3.15e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—INS—pancreatitis	3.11e-06	3.15e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—MDM2—pancreatitis	3.11e-06	3.14e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—ALB—pancreatitis	3.11e-06	3.14e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—INS—pancreatitis	3.11e-06	3.14e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—IL6—pancreatitis	3.11e-06	3.14e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—INS—pancreatitis	3.1e-06	3.14e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—INS—pancreatitis	3.09e-06	3.13e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—LPL—pancreatitis	3.09e-06	3.12e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—CASP3—pancreatitis	3.08e-06	3.12e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CCL2—pancreatitis	3.07e-06	3.1e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—IL6—pancreatitis	3.06e-06	3.1e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—INS—pancreatitis	3.06e-06	3.09e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CCL2—pancreatitis	3.06e-06	3.09e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—INS—pancreatitis	3.05e-06	3.09e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CCL2—pancreatitis	3.05e-06	3.08e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—NRAS—pancreatitis	3.04e-06	3.08e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CCL2—pancreatitis	3.04e-06	3.07e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—NRAS—pancreatitis	3.04e-06	3.07e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—NRAS—pancreatitis	3.02e-06	3.05e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CCL2—pancreatitis	3.01e-06	3.05e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CCL2—pancreatitis	3.01e-06	3.04e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—MDM2—pancreatitis	3e-06	3.04e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—NRAS—pancreatitis	3e-06	3.03e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—MDM2—pancreatitis	2.99e-06	3.02e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—PTGS2—pancreatitis	2.97e-06	3e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—NRAS—pancreatitis	2.96e-06	2.99e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—NRAS—pancreatitis	2.91e-06	2.94e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—CXCL8—pancreatitis	2.91e-06	2.94e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MDM2—pancreatitis	2.91e-06	2.94e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—HRAS—pancreatitis	2.89e-06	2.92e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—HRAS—pancreatitis	2.89e-06	2.92e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—KRAS—pancreatitis	2.88e-06	2.91e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—NRAS—pancreatitis	2.87e-06	2.9e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MDM2—pancreatitis	2.86e-06	2.89e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—ALB—pancreatitis	2.85e-06	2.88e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—INS—pancreatitis	2.84e-06	2.87e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—KRAS—pancreatitis	2.84e-06	2.87e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—KRAS—pancreatitis	2.83e-06	2.86e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—TGFB1—pancreatitis	2.83e-06	2.86e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—TGFB1—pancreatitis	2.83e-06	2.86e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—KRAS—pancreatitis	2.82e-06	2.85e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—KRAS—pancreatitis	2.81e-06	2.84e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CXCL8—pancreatitis	2.81e-06	2.84e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—TGFB1—pancreatitis	2.81e-06	2.84e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CXCL8—pancreatitis	2.79e-06	2.82e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CCL2—pancreatitis	2.79e-06	2.82e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—HRAS—pancreatitis	2.79e-06	2.82e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—CASP3—pancreatitis	2.78e-06	2.81e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—KRAS—pancreatitis	2.78e-06	2.81e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—KRAS—pancreatitis	2.78e-06	2.81e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—HRAS—pancreatitis	2.78e-06	2.81e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—IL6—pancreatitis	2.77e-06	2.8e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—IL6—pancreatitis	2.76e-06	2.79e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—NRAS—pancreatitis	2.75e-06	2.78e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—TGFB1—pancreatitis	2.75e-06	2.78e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—PTGS2—pancreatitis	2.72e-06	2.75e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CXCL8—pancreatitis	2.72e-06	2.75e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—TGFB1—pancreatitis	2.7e-06	2.73e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—HRAS—pancreatitis	2.7e-06	2.73e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CASP3—pancreatitis	2.69e-06	2.72e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CXCL8—pancreatitis	2.67e-06	2.7e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CASP3—pancreatitis	2.67e-06	2.7e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—IL6—pancreatitis	2.67e-06	2.7e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—TGFB1—pancreatitis	2.67e-06	2.7e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—HRAS—pancreatitis	2.66e-06	2.69e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—IL6—pancreatitis	2.66e-06	2.68e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MDM2—pancreatitis	2.64e-06	2.67e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—NRAS—pancreatitis	2.62e-06	2.65e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—KRAS—pancreatitis	2.62e-06	2.65e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—KRAS—pancreatitis	2.62e-06	2.64e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—LPL—pancreatitis	2.62e-06	2.64e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CASP3—pancreatitis	2.6e-06	2.63e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—KRAS—pancreatitis	2.6e-06	2.63e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MDM2—pancreatitis	2.6e-06	2.62e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MDM2—pancreatitis	2.59e-06	2.62e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—NRAS—pancreatitis	2.59e-06	2.61e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—IL6—pancreatitis	2.58e-06	2.61e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MDM2—pancreatitis	2.58e-06	2.61e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—KRAS—pancreatitis	2.58e-06	2.61e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GCG—pancreatitis	2.57e-06	2.6e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MDM2—pancreatitis	2.57e-06	2.6e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CASP3—pancreatitis	2.56e-06	2.59e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—TGFB1—pancreatitis	2.56e-06	2.58e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MDM2—pancreatitis	2.55e-06	2.57e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—KRAS—pancreatitis	2.55e-06	2.57e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—IL6—pancreatitis	2.54e-06	2.57e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MDM2—pancreatitis	2.54e-06	2.57e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—KRAS—pancreatitis	2.51e-06	2.53e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PTGS2—pancreatitis	2.49e-06	2.52e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—KRAS—pancreatitis	2.47e-06	2.5e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CXCL8—pancreatitis	2.47e-06	2.49e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—HRAS—pancreatitis	2.45e-06	2.48e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—TGFB1—pancreatitis	2.43e-06	2.46e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CXCL8—pancreatitis	2.43e-06	2.45e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CXCL8—pancreatitis	2.42e-06	2.45e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CXCL8—pancreatitis	2.41e-06	2.44e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—HRAS—pancreatitis	2.41e-06	2.44e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CXCL8—pancreatitis	2.41e-06	2.43e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—HRAS—pancreatitis	2.41e-06	2.43e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—TGFB1—pancreatitis	2.4e-06	2.43e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—HRAS—pancreatitis	2.4e-06	2.42e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—HRAS—pancreatitis	2.39e-06	2.42e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CXCL8—pancreatitis	2.38e-06	2.41e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CXCL8—pancreatitis	2.38e-06	2.4e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—HRAS—pancreatitis	2.37e-06	2.39e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—KRAS—pancreatitis	2.37e-06	2.39e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MDM2—pancreatitis	2.36e-06	2.39e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—HRAS—pancreatitis	2.36e-06	2.39e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CASP3—pancreatitis	2.36e-06	2.39e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—IL6—pancreatitis	2.34e-06	2.37e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—NRAS—pancreatitis	2.33e-06	2.36e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CASP3—pancreatitis	2.32e-06	2.35e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CASP3—pancreatitis	2.32e-06	2.34e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CASP3—pancreatitis	2.31e-06	2.33e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—IL6—pancreatitis	2.31e-06	2.33e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CASP3—pancreatitis	2.3e-06	2.33e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—IL6—pancreatitis	2.3e-06	2.33e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—IL6—pancreatitis	2.29e-06	2.32e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—IL6—pancreatitis	2.29e-06	2.31e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CASP3—pancreatitis	2.28e-06	2.3e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CASP3—pancreatitis	2.27e-06	2.3e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—IL6—pancreatitis	2.27e-06	2.29e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—IL6—pancreatitis	2.26e-06	2.28e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—KRAS—pancreatitis	2.26e-06	2.28e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PPARG—pancreatitis	2.25e-06	2.28e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—NRAS—pancreatitis	2.25e-06	2.28e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—NRAS—pancreatitis	2.24e-06	2.27e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—HRAS—pancreatitis	2.23e-06	2.25e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—KRAS—pancreatitis	2.23e-06	2.25e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—HRAS—pancreatitis	2.22e-06	2.25e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—INS—pancreatitis	2.21e-06	2.23e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—HRAS—pancreatitis	2.21e-06	2.23e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CXCL8—pancreatitis	2.21e-06	2.23e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—HRAS—pancreatitis	2.19e-06	2.22e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—NRAS—pancreatitis	2.18e-06	2.2e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TGFB1—pancreatitis	2.17e-06	2.19e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—HRAS—pancreatitis	2.16e-06	2.19e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—NRAS—pancreatitis	2.15e-06	2.17e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—IL6—pancreatitis	2.13e-06	2.15e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—HRAS—pancreatitis	2.13e-06	2.15e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—IL6—pancreatitis	2.13e-06	2.15e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—IL6—pancreatitis	2.12e-06	2.14e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CASP3—pancreatitis	2.11e-06	2.14e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—HRAS—pancreatitis	2.1e-06	2.12e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—IL6—pancreatitis	2.1e-06	2.12e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TGFB1—pancreatitis	2.09e-06	2.12e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TGFB1—pancreatitis	2.08e-06	2.1e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—IL6—pancreatitis	2.07e-06	2.09e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—IL6—pancreatitis	2.04e-06	2.06e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—ALB—pancreatitis	2.03e-06	2.05e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TGFB1—pancreatitis	2.03e-06	2.05e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—LPL—pancreatitis	2.02e-06	2.04e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—HRAS—pancreatitis	2.01e-06	2.03e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—IL6—pancreatitis	2.01e-06	2.03e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—KRAS—pancreatitis	2.01e-06	2.03e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TGFB1—pancreatitis	1.99e-06	2.01e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—NRAS—pancreatitis	1.98e-06	2e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—NRAS—pancreatitis	1.95e-06	1.97e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—NRAS—pancreatitis	1.94e-06	1.96e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—KRAS—pancreatitis	1.94e-06	1.96e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—NRAS—pancreatitis	1.94e-06	1.96e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—NRAS—pancreatitis	1.93e-06	1.95e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—KRAS—pancreatitis	1.93e-06	1.95e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—IL6—pancreatitis	1.93e-06	1.95e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—HRAS—pancreatitis	1.92e-06	1.94e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—NRAS—pancreatitis	1.91e-06	1.93e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PPARG—pancreatitis	1.91e-06	1.93e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—NRAS—pancreatitis	1.91e-06	1.93e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—HRAS—pancreatitis	1.89e-06	1.91e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—KRAS—pancreatitis	1.88e-06	1.9e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—INS—pancreatitis	1.87e-06	1.89e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—KRAS—pancreatitis	1.85e-06	1.87e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TGFB1—pancreatitis	1.84e-06	1.86e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—IL6—pancreatitis	1.83e-06	1.85e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—IL6—pancreatitis	1.81e-06	1.83e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TGFB1—pancreatitis	1.81e-06	1.83e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TGFB1—pancreatitis	1.8e-06	1.82e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TGFB1—pancreatitis	1.8e-06	1.82e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TGFB1—pancreatitis	1.79e-06	1.81e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TGFB1—pancreatitis	1.78e-06	1.79e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PTGS2—pancreatitis	1.77e-06	1.79e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TGFB1—pancreatitis	1.77e-06	1.79e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—NRAS—pancreatitis	1.77e-06	1.79e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—ALB—pancreatitis	1.72e-06	1.74e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—HRAS—pancreatitis	1.71e-06	1.73e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—KRAS—pancreatitis	1.7e-06	1.72e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—KRAS—pancreatitis	1.68e-06	1.69e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—KRAS—pancreatitis	1.67e-06	1.69e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—KRAS—pancreatitis	1.67e-06	1.68e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—KRAS—pancreatitis	1.66e-06	1.68e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—HRAS—pancreatitis	1.65e-06	1.67e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TGFB1—pancreatitis	1.65e-06	1.66e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—KRAS—pancreatitis	1.64e-06	1.66e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—KRAS—pancreatitis	1.64e-06	1.66e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—HRAS—pancreatitis	1.64e-06	1.66e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—IL6—pancreatitis	1.63e-06	1.65e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—HRAS—pancreatitis	1.6e-06	1.61e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—IL6—pancreatitis	1.58e-06	1.59e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—HRAS—pancreatitis	1.57e-06	1.59e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—IL6—pancreatitis	1.57e-06	1.59e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IL6—pancreatitis	1.53e-06	1.54e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—KRAS—pancreatitis	1.52e-06	1.54e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PTGS2—pancreatitis	1.5e-06	1.52e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IL6—pancreatitis	1.5e-06	1.52e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PPARG—pancreatitis	1.47e-06	1.49e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—HRAS—pancreatitis	1.45e-06	1.46e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—INS—pancreatitis	1.45e-06	1.46e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—HRAS—pancreatitis	1.42e-06	1.44e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—HRAS—pancreatitis	1.42e-06	1.44e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—HRAS—pancreatitis	1.42e-06	1.43e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—HRAS—pancreatitis	1.41e-06	1.43e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—HRAS—pancreatitis	1.4e-06	1.41e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—HRAS—pancreatitis	1.39e-06	1.41e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IL6—pancreatitis	1.39e-06	1.4e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IL6—pancreatitis	1.36e-06	1.38e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IL6—pancreatitis	1.36e-06	1.37e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IL6—pancreatitis	1.36e-06	1.37e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IL6—pancreatitis	1.35e-06	1.37e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IL6—pancreatitis	1.34e-06	1.35e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IL6—pancreatitis	1.33e-06	1.35e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ALB—pancreatitis	1.33e-06	1.34e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—HRAS—pancreatitis	1.3e-06	1.31e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL6—pancreatitis	1.24e-06	1.25e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PTGS2—pancreatitis	1.16e-06	1.17e-05	CbGpPWpGaD
